Aiberry
Array
Overview
Aiberry offers an AI-powered platform for mental health screening and care navigation, designed to assist providers and payers in identifying and guiding individuals to appropriate care. It provides anonymous mental health screenings, acting as a digital front door to mental health engagement. The platform aims to lower barriers to seeking help, gain actionable insights through analytics, and guide users to the next steps, with a strong emphasis on privacy and trust. Aiberry does not replace counseling or clinical care but serves as an early, supportive touchpoint, helping individuals understand their experiences and directing them toward appropriate resources like counseling or clinical care when needed. The platform leverages AI and natural language processing (NLP) to conduct interactive conversations, analyzing text, audio, and visual cues to provide real-time mental health assessments. It delivers quantified risk scores and health insights to providers, enabling more informed clinical decisions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Anonymous mental health screenings
- AI voice + visual assessment (SmartAI MindCare)
- Digital MindCare for quick check-ins
- Actionable insights and analytics for organizations
- Personalized insights and resources for users
- Privacy and trust-focused design
- AI-powered therapeutic assistant (Botberry)
- Analysis of text, audio, and video cues
- Real-time mental health scoring and results
- Clinically validated assessment model
Use Cases
- Early mental health engagement and detection
- Supporting individuals in education settings
- Supporting individuals in workplace settings (Corporate Wellness)
- Supporting individuals in clinical settings (Behavioral Health & Recovery)
- Research and technology in mental health
- Telehealth and remote patient monitoring
What Physicians Need to Know
Therapeutic Modality
Aiberry functions primarily as an AI-powered mental health screening and assessment tool, analyzing text, audio, and video cues during bot-administered interviews to detect conditions like depression and anxiety. It provides insights for diagnosis and treatment planning rather than directly delivering specific therapeutic modalities like CBT, DBT, or ACT.
Crisis Detection & Escalation
The platform provides a quantified risk score for mental health disorders, including suicidal ideation, and offers alerts to major changes in a user's mental health condition. The provider dashboard can display 'high suicidal risk alert' and risk trend graphs.
PHQ-9/GAD-7 Integration
Aiberry's AI assessment has demonstrated clinical equivalence to 'gold-standard depression questionnaires' like the PHQ-9 and aims to predict responses to self-report questionnaires for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD). Studies suggest it can be more sensitive than traditional screening methods in detecting depression.
Patient Safety Guardrails
Aiberry's AI platform is designed with machine learning pipelines to eliminate biases related to age, gender, sexual orientation, and race, with clinical validation studies showing no evidence of such biases. It incorporates state-of-the-art security and encryption measures to ensure privacy and data security.
Between-Session Support
Aiberry offers continuous mental health monitoring through self-screenings available 24/7 from any location, allowing users to check in on their mental health via a mobile app.
Outcome Measurement
The tool delivers real-time mental health scoring, results, and tracks trends and progress over time. It provides symptom analysis for mood, concentration, and energy, along with risk level scores for mental health disorders, which are crucial for creating personalized treatment plans and monitoring progress.
Provider Dashboard
Aiberry features a user-friendly online dashboard for clinicians, offering a comprehensive view of patient progress, ongoing screening results, and trends. It provides alerts for major changes in mental health conditions and can display high suicidal risk alerts and risk trend graphs.
Cultural Sensitivity
The AI platform is trained using data from a wide-ranging demographic and its machine learning pipelines are designed to eliminate biases related to age, gender, sexual orientation, and race. Clinical studies have confirmed no evidence of such biases. It is also WCAG Section 508 compliant.
Physician Tip
Physicians can leverage Aiberry for objective, efficient, and continuous mental health screening and monitoring, aiding in early detection and providing quantifiable risk scores and symptom insights. The platform's ability to offer more sensitive detection than traditional questionnaires can augment clinical judgment. Utilize the provider dashboard for a centralized view of patient progress and to receive alerts for significant changes, facilitating timely intervention and treatment plan adjustments.
Aiberry is designed for easy integration with leading corporate wellness platforms and existing healthcare workflows, serving as a supplement to clinical evaluation. It has partnered with platforms like MedPass to embed its AI technology for real-time assessments. For certain deployments, such as in higher education, it is noted for requiring no technical integrations, suggesting a standalone or easily embeddable solution.
Details
| Category | Mental & Behavioral Health AI |
| Pricing | Array — Digital MindCare: $199/month; SmartAI MindCare: $399/month; Custom Enterprise Solutions: Contact Us |
| Deployment | Web-based, Cloud-hosted |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status | Unknown AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Family Medicine, Internal Medicine, Psychiatry |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Aiberry
Press & Coverage
PubMed / Journal of Affective Disorders
Conversational assessment using artificial intelligence is as clinically useful as depression scales and preferred by users
A study published in the Journal of Affective Disorders found that Aiberry's AI platform accurately assesses mental health by analyzing text, audio, and video cues during a bot-administered interview, performing as well as standard questionnaires and showing no bias related to gender, age, or race.
2024-04
Aiberry (via Business Wire)
Aiberry Introduces AI-Powered Mental Health Assessments for Corporate Wellness Platforms
Aiberry launched a new version of its AI platform specifically for corporate wellness programs, utilizing its 'Botberry' therapeutic assistant to detect mental health disorders through conversational analysis.
2024-02
BioWorld
Aiberry files new patents for AI-powered mental health assessment platform
Aiberry Inc. filed new patent applications for its AI-powered mental health screening platform, which uses trained AI models to analyze words, sounds, and video from patient conversations to detect indicators of mental health.
2023-12
Aiberry
Aiberry Addresses Growing U.S. Mental Health Needs; Adds Comprehensive Screening Tool Covering Five Major Anxiety Disorders to AI-Powered Assessment Platform
Aiberry expanded its AI-powered mental health assessment platform to include comprehensive screening for five major anxiety disorders, in addition to its existing depression assessments.
2023-11
Aiberry
Aiberry Named Best Mental Health Technology Solution in the Health Digital Tech Awards 2023
Aiberry was recognized as the Best Mental Health Technology Solution of 2023 by the Health Digital Tech Awards, an award program that highlights top companies and technologies in health tech.
2023-04
GeekWire
Seattle-area startup using AI for mental health screening tech raises $8M
Seattle-based Aiberry raised $8 million in seed funding for its AI-powered software that analyzes audio, visual, and language from short conversations to screen for mental health conditions like depression, anxiety, and suicidal ideation.
2023-03
Built In Seattle
Aiberry Raises $8M for AI-Powered Mental Health Screenings
Aiberry secured $8 million in seed funding, led by Confluence Capital Group, to advance its AI-powered therapeutic assistant that screens patients for mental health conditions by analyzing statements, speech patterns, and facial expressions.
2023-03
Healio
Aiberry secures $8M to promote AI-powered mental health screening platform
Aiberry announced $8 million in seed funding, led by Confluence Capital Group Inc. and Ascension AI, to accelerate the adoption of its AI-powered platform, which uses a therapeutic assistant to detect mental health disorders through conversational analysis.
2023-03
Videos
Product demos, reviews, and walkthroughs for Aiberry.
Aiberry Screening Demo
Aiberry
Frequently Asked Questions
Aiberry serves as an AI-powered mental health screening solution, analyzing patient text, audio, and video cues during a bot-administered conversation to provide a quantified risk score and insights for conditions like depression and anxiety. It aims to streamline the initial screening process, replacing traditional paper forms and offering real-time assessments to support clinical decision-making, rather than providing a diagnosis.
Yes, Aiberry operates with a HIPAA-compliant data infrastructure, ensuring patient privacy and confidentiality. All data on the platform is encrypted, information used for analytics is anonymized, and any data from the mental health screening process is deleted and removed. Protected Health Information (PHI) is only shared with authorized service providers after explicit patient consent.
Aiberry is designed as a preliminary screening tool and is explicitly not a diagnostic tool or a replacement for medical diagnosis, clinical evaluation, or treatment. Its limitations include reliance on user self-reported data, potential for limited integration with certain health platforms, and the inherent constraints of a chatbot in understanding complex individual experiences.
Aiberry has undergone clinical validation, demonstrating that its model for depression risk is clinically equivalent to gold-standard depression questionnaires. The Machine Learning pipelines are specifically designed to eliminate biases related to age, gender, sexual orientation, and race, with studies showing no differential model performance across these demographics.
Aiberry offers different pricing tiers, including Digital MindCare at $199 per month for digital screenings and SmartAI MindCare at $399 per month, which includes AI voice and visual assessment. For more tailored needs, Custom Enterprise Solutions are available, requiring direct contact for pricing.
While Aiberry focuses on AI-powered screening, alternatives and complementary tools include broader practice management and EHR solutions like SimplePractice, TheraNest, and Valant EHR Suite. Other AI-driven mental health tools such as Woebot Health for CBT support or Eleos Health for session note automation also exist.
Aiberry is designed to integrate with existing healthcare workflows and can be integrated with leading corporate wellness platforms and potentially EMR/EHR systems, though specific integration capabilities may vary. It provides assessment reports and risk scores that clinicians can use to support diagnostic decisions and can automate existing workflows.
Suggest an Edit →
| Last Verified: 2026-04-21 | First Added: 2026-04-21